Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The method can effectively extract biomedical information without needing expert annotation, performing better than previous models.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

High androgen levels in young women with PCOS are linked to higher blood pressure.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Periodontal ligament stem cells show promise for regrowing tissues but require more research for safe, effective use.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

All adults have Demodex mites, which vary by region.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

SHBG may be a useful early indicator and treatment target for PCOS.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Eating glucoraphanin can help prevent psychosis in offspring whose mothers had immune system activation.

People's decision-making can be influenced by their internal biological clocks, as shown by gene expression, not just self-reported preferences for morning or evening.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Fractional resurfacing is safe and effective for certain skin conditions in Asian patients, but care must be taken to avoid skin pigmentation issues.

Type I interferons play a key role in the development of various skin diseases.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Women with high androgen levels may have more severe COVID-19 symptoms.